Arabian International Healthcare Holding Company
TADAWUL:9530.SR
38.1 (SAR) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 806.924 | 642.7 | 618.54 | 818.689 | 697.033 |
| Cost of Revenue
| 630.081 | 488.5 | 475.021 | 620.309 | 525.689 |
| Gross Profit
| 176.843 | 154.2 | 143.518 | 198.38 | 171.344 |
| Gross Profit Ratio
| 0.219 | 0.24 | 0.232 | 0.242 | 0.246 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 18.151 | 12.667 | 9.552 | 9.915 | 8.924 |
| Selling & Marketing Expenses
| 19.243 | 14.644 | 9.406 | 10.245 | 9.25 |
| SG&A
| 130.124 | 109.1 | 18.958 | 20.16 | 18.174 |
| Other Expenses
| 1.479 | 2.826 | 72.003 | 79.9 | 72.296 |
| Operating Expenses
| 130.124 | 109.1 | 90.96 | 100.06 | 90.47 |
| Operating Income
| 46.719 | 45.1 | 74.571 | 110.222 | 82.346 |
| Operating Income Ratio
| 0.058 | 0.07 | 0.121 | 0.135 | 0.118 |
| Total Other Income Expenses Net
| 9.239 | -10.6 | 19.167 | 9.568 | -25.618 |
| Income Before Tax
| 55.957 | 34.5 | 93.738 | 119.79 | 56.729 |
| Income Before Tax Ratio
| 0.069 | 0.054 | 0.152 | 0.146 | 0.081 |
| Income Tax Expense
| 11.574 | 10.9 | 11.424 | 24 | 15.6 |
| Net Income
| 38.088 | 20.474 | 82.314 | 95.79 | 41.129 |
| Net Income Ratio
| 0.047 | 0.032 | 0.133 | 0.117 | 0.059 |
| EPS
| 1.92 | 1.29 | 4.12 | 4.79 | 2.06 |
| EPS Diluted
| 1.92 | 1.02 | 4.12 | 4.79 | 2.06 |
| EBITDA
| 62.003 | 67.743 | 81.806 | 117.753 | 115.972 |
| EBITDA Ratio
| 0.077 | 0.105 | 0.132 | 0.144 | 0.166 |